Beaird Harris Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.8K | Hold |
224
| – | – | 0.01% | 191 |
|
|
2025
Q1 | $111K | Hold |
224
| – | – | 0.01% | 159 |
|
|
2024
Q4 | $117K | Hold |
224
| – | – | 0.01% | 161 |
|
|
2024
Q3 | $139K | Buy |
224
+199
| +796% | +$123K | 0.01% | 155 |
|
|
2024
Q2 | $13.6K | Sell |
25
-11
| -31% | -$5.97K | ﹤0.01% | 342 |
|
|
2024
Q1 | $20.9K | Sell |
36
-9
| -20% | -$5.23K | ﹤0.01% | 274 |
|
|
2023
Q4 | $23.9K | Buy |
45
+31
| +221% | +$16.5K | ﹤0.01% | 247 |
|
|
2023
Q3 | $7.09K | Hold |
14
| – | – | ﹤0.01% | 285 |
|
|
2023
Q2 | $7.31K | Hold |
14
| – | – | ﹤0.01% | 288 |
|
|
2023
Q1 | $8.07K | Sell |
14
-9
| -39% | -$5.19K | ﹤0.01% | 286 |
|
|
2022
Q4 | $12.7K | Buy |
23
+9
| +64% | +$4.96K | ﹤0.01% | 300 |
|
|
2022
Q3 | $7K | Hold |
14
| – | – | ﹤0.01% | 318 |
|
|
2022
Q2 | $8K | Sell |
14
-209
| -94% | -$119K | ﹤0.01% | 270 |
|
|
2022
Q1 | $132K | Buy |
223
+9
| +4% | +$5.33K | 0.05% | 107 |
|
|
2021
Q4 | $143K | Buy |
+214
| New | +$143K | 0.05% | 131 |
|